Sommaire

• • ·Editorial board

    Page :I

    
• • ·Editorial

    Page :7-8

    Résumé Résumé Plan Plan
• • ·Editorial

    Page :9-10

    Résumé Résumé Plan Plan
• • ·Authors Index (Abstract number)

    Page :125-132

    Résumé Résumé Plan Plan
• • ·Authors Index (Category)

    Page :133-142

    Résumé Résumé Plan Plan
• • ·Authors Index (Page)

    Page :143-150

    Résumé Résumé Plan Plan

• Topic 01 - Coronary artery disease

  • ·Does immediate complete revascularization improve in-hospital outcomes in STEMI patients with multivessel disease treated with primary angioplasty? Insights from the ORBI registry

    Page :11

    V. Auffret, M. Bedossa, D. Boulmier, G. Leurent, R. Delaunay, P. Castellant, J.P. Hacot, E. Filippi, D. Saouli, G. Rouault, P. Druelles, M. Le Guellec, M. Gilard, H. Le Breton

    
  • ·Influence of gender in ST-segment elevation myocardial infarction: insight from the first French metaregistry

    Page :12

    S. Manzo-Silberman, F. Couturaud, S. Charpentier, V. Auffret, C. El Khoury, H. Le Breton, L. Belle, S. Marliere, M. Zeller, Y. Cottin, N. Danchin, T. Simon, F. Schiele, M. Gilard

    
  • ·The success of thrombectomy does not prevent angiographically visible distal embolization in STEMI patients treated by primary percutaneous coronary intervention and thrombectomy

    Page :12

    V. Yameogo, K. Stamboul, C. Richard, A. Gudjoncik, J. Hamblin, P. Buffet, I. L’huillier, L. Lorgis, Y. Cottin

    
  • ·Analysis of mortality rate in patients with ST-segment elevation myocardial infarction: the SCALIM registry

    Page :12

    E. Martins, J. Magne, V. Pradelle, G. Faugeras, D. Caillloce, D. Mohty, E. Fleurant, H. Karam, P.B. Petitcolin, P. Virot, V. Aboyans

    
  • ·Drift evaluation after FFR measurements

    Page :12-13

    C. Pouillot, K. Bougrini, R. Vi Fane, G. Rambaud, J. Glasenapp, C. Geyer, J. Adjedj

    Résumé Résumé Plan Plan
  • ·Fractional flow reserve (FFR) and angiographic estimation correlation of coronary stenoses: the impact of risk factors

    Page :13

    J. Adjedj, P. Xamplanteris, G. Toth, A. Ferrara, V. Flore, M. Pellicano, E. Barbato, B. De Bruyne

    
  • ·Comparison of the instantaneous wave-free ratio and resting Pd/Pa with fractional flow reserve to assess coronary artery stenosis of intermediate severity

    Page :13

    J. Clerc, P. Meimoun, A. Luycx-Bore, U. Djou, S. Martis, T. Botoro, F. Elmkies, H. Zemir

    
  • ·Coronary Fractional Flow Reserve (FFR) measurement: which method of adenosine administration is the safest?

    Page :13-14

    M. Calcaianu, D. Bresson, Y. Doghmi, C. Vilbois, T. El Nazer, A. Felder, L. Lachmet-Teebaud, J. Wiedemann, O. Roth, L. Jacquemin, J. Levy

    Résumé Résumé Plan Plan
  • ·Contrast media induced nephropathy prevention for patients at risk: matched diuresis evaluation

    Page :14

    J. Dally

    
  • ·Percutaneous coronary interventions with drug eluting stents in the elderly: the experience of a tertiary Tunisian cardiac center

    Page :14-15

    S. Charfeddine, L. Abid, R. Hammami, I. Chamtouri, M. Baccouche, S. Mallek, A. Maalej, D. Abid, S. Kammoun

    Résumé Résumé Plan Plan
  • ·Impact of diabetes on early and midterm outcomes of coronary artery bypass graft surgery in patients with left ventricular dysfunction

    Page :15

    H. Bennani, I. Asfalou, F. Benaich, Z. Lakhal, M. Ait Houssa

    
  • ·Depression and anxiety in coronary artery bypass grafting patients: comparisons with percutaneous intervention

    Page :15

    B. Herbegue, S. Chenik, D. Lahidheb, H. Haouala

    
  • ·Acute coronary syndromes in the very elderly: short term prognostic performance of the SYNTAX score

    Page :15-16

    L. Faroux, S. Tassan-Mangina, B. Herce, P. Nazeyrollas, K. Bauley, D. Metz

    Résumé Résumé Plan Plan
  • ·Agreement among the three metabolic syndrome definitions and their performance in the prediction of acute coronary syndrome

    Page :16

    M. Allal-Elasmi, W. Zidi, Y. Zayani, M. Ben Khalifa, H. Sanhaji, M.B. Hammami, R. Jemaa, S. Hadjtaieb, M. Feki, A. Mebazaa, N. Kaabachi

    
  • ·Comparison of serum uric acid and C-reactive protein as novel cardiovascular risk factors and their correlation with the Framingham risk score: a cross-sectional study in great Tunis region (Tunisia)

    Page :16-17

    W. Zidi, M. Allal-Elasmi, N. Fourty, Y. Zayani, H. Sanhaji, M.B. Hammami, S. Hadjtaieb, R. Jemaa, M. Hsairi, M. Feki, A. Mebazaa, N. Kaabachi

    Résumé Résumé Plan Plan
  • ·Treshold value of admission glycemia predictive of higher in-hospital mortality during STEMI in non-diabetic patients

    Page :17

    A. Talamali, S. Heddi, S. Feliachi, I. Makhdoul, M. Haddak, N. Adjeroud

    
  • ·Prevalence for undiagnosed diabetes in acute phase of STEMI

    Page :17

    A. Talamali, S. Heddi, S. Feliachi, I. Makhdoul, M. Haddak, N. Adjeroud

    
  • ·Results and prognosis factors associated with percutaneous coronary interventions for left main coronary artery disease

    Page :17-18

    M. Slim, A. Lagran, A. Sebri, R. Amara, A. Meddeb, E. Neffati, R. Gribaa, F. Remadi, E. Boughzela

    Résumé Résumé Plan Plan
  • ·Coronary procedures in patients treated by TAVI with the self-expanding aortic bioprosthesis Medtronic CoreValve ©, not an easy matter

    Page :18

    M. Boukantar, R. Gallet, G. Mouillet, E. Teiger

    
  • ·Repeated stenosis of both main coronary ostia in Takayasu disease treated by successive angioplasties

    Page :18

    L. Fanon, B. Terrier, O. Varenne, J. Emmerich

    
  • ·Evaluation of the safety and efficacy of the Cobra PzF NanoCoated Coronary Stent (NCS) in 1 000 all-comers, consecutive, prospective, high risk patients: the e-Cobra Registry

    Page :18-19

    R. Ratini, Luc Maillard, Loic Belle, Jacques Berland, Axel de Labriolle

    Résumé Résumé Plan Plan
  • ·Impact of plaque morphology as assessed by optical coherence tomography on procedural outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention

    Page :19

    N. Braik, B. Bonnet, B. Genet, M. Chatot, R. Chopard, M.F. Seronde, F. Schiele, N. Meneveau

    
  • ·Systemic inflammation after transradial coronary angiogram: statistically (but not clinically) significant?

    Page :19

    M. Akodad, F. Hammer, S. Aguilhon, J.P. Cristol, F. Leclercq, J.C. Macia, R. Gervasoni, B. Lattuca, A.M. Dupuy, F. Roubille

    
  • ·Prevention of acute kidney injury in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention by 5-lipoxygenase inhibitor corvitin (“case-match-control” study)

    Page :19

    A. Parkhomenko, O. Shumakov

    
  • ·Association of C677T MTHFR and G20210A FII prothrombin polymorphisms with susceptibility to myocardial infarction in Morocco

    Page :19-20

    W. Hmimech, H. Hassani Idrissi, B. Diakité, D. Baghdadi, F. Korchi, R. Habbal, S. Nadifi

    Résumé Résumé Plan Plan
  • ·Association of G894T eNOS, 4G/5G PAI and T1131C APOA5 polymorphisms with susceptibility to myocardial infarction in Morocco

    Page :20

    H. Hassani Idrissi, W. Hmimech, B. Diakité, F. Korchi, D. Baghdadi, R. Habbal, S. Nadifi

    
  • ·G2691A and C2491T mutations of FV gene and predisposition to myocardial infarction in Morroco

    Page :20

    W. Hmimech, B. Diakité, H. Hassani Idrissi, K.H. Hamzi, F. Korchi, D. Baghdadi, R. Habbal, S. Nadifi

    
  • ·The role of bile acids and gut microbiota in coronary artery disease: results of the MABAC study in human (microbiota atheroma and bile acid in coronary disease)

    Page :20-21

    C. Chong-Nguyen, H. Duboc, D. Rainteau, L. Humbert, H. Sokol, A. Bado, S. Weber, O. Varenne, D. Duboc

    Résumé Résumé Plan Plan
  • ·Is matrix metalloprotease-8 a novel predictor of coronary artery disease?

    Page :21

    I. Guizani, W. Zidi, Y. Zayani, S. Aloui, N. Fourty, A. Zaroui, B. Hammami, H. Sanhaji, S. Hadj Taib, R. Jemaa, M. Feki, R. Mechmech, M.S. Mourali, M. Allal Elasmi, N. Kaabachi

    
  • ·Recurrence of ischemic events after stopping clopidogrel in Tunisian patients with acute coronary syndrome

    Page :21

    I. Ben Ali, M. Boussadia, S. Hamdi, A. Elhraiech, W. Jomaa, M.A. Azaiez, K. Ben Hamda, F. Maatouk

    
  • ·Low blood pressure 48 hours after myocardial infarction is predictive of long-term mortality

    Page :21-22

    G. Cartigny, K. Stamboul, M. Zeller, J.C. Beer, Y. Cottin

    Résumé Résumé Plan Plan
  • ·Gender differences in cardiogenic shock after acute myocardial infarction. The FAST-MI programme

    Page :22

    E. Puymirat, N. Aissaoui, D. Angoulvant, P. Goldstein, G. Ducrocq, F. Schiele, J. Ferrières, T. Simon, N. Danchin

    
  • ·Myocardial infarction after kidney transplantation: a specific profile. Analysis from a French nationwide hospital medical information database

    Page :22

    K. Stamboul, S. Philibert, J. Cottenet, C. Mousson, L. Lorgis, C. Quantin, Y. Cottin

    
  • ·Coronary artery disease among black African diabetics patients: insights from an Ivorian cardiac catheterization center

    Page :22-23

    C. Yao, R. N’guetta, A. Ekou, I. Angoran, M.P. N’cho-Mottoh, E. Soya, J.B. Anzouan-Kacou, A.M. Adoh, R. Seka

    Résumé Résumé Plan Plan
  • ·Outcomes of primary coronary angioplasty in women

    Page :23

    D. Mlayeh, R. Gribaa, E. Neffetti, F. Remadi, E. Boughzela

    
  • ·Impact of P2Y12 inhibitors preloading on one year event free survival in patients treated by primary PCI for ST elevation myocardial infarction

    Page :23

    A. Nyssen, J. Magne, V. Legrand, L. Pierard, O. Gach

    
  • ·Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: OLTAT registry

    Page :23

    Q. Fischer, G. Helft, J.P. Collet, E. Berman, S. Cohen, I. Jolivet, F. Laveau, C. Le Feuvre

    
  • ·Effect of rapid desensitization on platelet inhibition and basophil activation in patients with aspirin hypersensitivity and coronary disease

    Page :24

    S. Manzo-Silberman, P. Nicaise-Roland, C. Neukirch, F. Tubach, M.G. Huisse, S. Chollet-Martin, H. Abergel, F. Driss, T. Alfaiate, N. Ajzenberg, G. Steg

    
  • ·Switching from clopidogrel to prasugrel in ST-elevation myocardial infarction treated with thrombolysis, an observational study

    Page :24

    T. Chollet, T. Lhermusier, M. Galinier, D. Carrie

    
  • ·What is the optimal duration of dual antiplatelet therapy after acute coronary syndrome in the elderly?

    Page :24

    A. Lemaitre, V. Roule, K. Blanchart, P. Ardouin, J. Alexandre, C. Briet, M. Aabouni, J. Wain-Hobson, M. Bignon, R. Sabatier, P. Milliez, F. Beygui

    
  • ·Radial artery spasm: prevalence, prevention and safety vasodilators agents in a prospective randomized meta-analysis

    Page :24-25

    J. Adjedj, R. Jakamy, A. Diallo, J. Rosencher, P. Degrell, E. Salengro, A. Jegou, P. Allouch, S. Linard, O. Varenne

    Résumé Résumé Plan Plan
  • ·Incidence, timing, predictors and impact of acute heart failure complicating ST-segment elevation myocardial infarction in patients treated by primary percutaneous coronary intervention

    Page :25

    V. Auffret, G. Leurent, M. Gilard, J.P. Hacot, E. Filippi, R. Delaunay, A. Rialan, G. Rouault, P. Druelles, P. Castellant, I. Coudert, B. Boulanger, J. Treuil, E. Bot, M. Bedossa, D. Boulmier, M. Le Guellec, E. Donal, H. Le Breton

    
  • ·Prognosis of acute right ventricular failure as the primary cause of cardiogenic shock complicating ST-segment elevation myocardial infarction

    Page :25-26

    S. Boudiche, F. El Ayech, S. Hannachi, M. Ben Halima, H. Aloui, N. Khader, S. Ouali, F. Mghaeith, N. Larbi, M.S. Mourali

    Résumé Résumé Plan Plan
  • ·Six years follow-up of patient’s adherence to medical, biological and clinical optimal therapy and recommendations after myocardial infarction

    Page :26

    J. Peurois, C. Dibao

    
  • ·Early discharge strategy after a ST-segment elevation myocardial infarction: safety assessment at one-year follow-up

    Page :26

    F. Good, B. Harbaoui, E. Bonnefoy-Cudraz, C. El Khoury, T. Bochaton

    
  • ·Predictors of in-hospital occurrence of cardiogenic shock in STEMI patients presenting with acute heart failure on admission and treated with primary percutaneous coronary intervention

    Page :26-27

    V. Auffret, G. Leurent, M. Bedossa, D. Boulmier, P. Castellant, E. Filippi, R. Delaunay, J.P. Hacot, G. Rouault, D. Saouli, P. Druelles, M. Le Guellec, M. Gilard, H. Le Breton

    Résumé Résumé Plan Plan
  • ·The stress hyperglycemia in the acute phase of a STEMI: a residual risk in the era of primary angioplasty?

    Page :27

    A. Talamali, S. Heddi, S. Feliachi, I. Makhdoul, M. Haddak, N. Adjeroud

    
  • ·Value of fragmented QRS in STEMI patients undergoing primary percutaneous coronary intervention in predicting left ventricular remodeling

    Page :27

    O. Hamza

    
  • ·ST elevation myocardial infarction in the elderly (about 120 cases)

    Page :27-28

    A. Jalled, N. Ben Halima

    Résumé Résumé Plan Plan
  • ·Relathionship between high risk scintigraphic score and elevated REACH score in 6 months after a first acute coronary syndrome

    Page :28

    E. Noirot, O. Humbert, K. Stamboul, T. Leclerc, M. Zeller, L. Lorgis, Y. Cottin, A. Cochet

    
  • ·Assessment of signs of coronary reperfusion in STEMI after thrombolysis in “Early presenters”

    Page :28

    A. Talamali, S. Heddi, S. Feliachi, I. Makhdoul, M. Haddak, N. Adjeroud

    

• Topic 02 - Heart failure and cardiomyopathies

  • ·Assessment of the French access to heart transplantation considering the competing risk of death to improve organ allocation policy

    Page :41

    C. Cantrelle, C. Legeai, A. Latouche, P. Tuppin, R. Dorent, O. Bastien

    
  • ·Cardiac dysautonomia predicts long term survival in transthyretin amyloidosis

    Page :29

    V. Algalarrondo, T. Antonini, M. Theaudin, D. Chemla, A. Benmalek, C. Lacroix, D. Castaing, C. Cauquil, S. Dinanian, L. Eliahou, D. Samuel, D. Adams, F. Rouzet, D. Le Guludec, M.S. Slama

    
  • ·Outcome of cardiac amyloidosis admitted in intensive care unit

    Page :29

    T. D’humières, T. Damy, J.L. Dubois-Randé, P. Lim, J. Ternacle

    
  • ·Prevalence and clinical impact of pulmonary hypertension on survival in patients with light chains amyloidoisis

    Page :29

    V. Didot, D. Mohty, J. Magne, A. Laarje, D. Lavergne, B. Fadel, V. Aboyans, A. Jaccard

    
  • ·Prognostic value of the systolic and diastolic function of the right ventricular on hypertrophic cardiomyopathy

    Page :30

    R. Mechmeche, A. Zaroui, H. Zargouni, M.F. Drissi

    
  • ·Early phase of HMDP scintigraphy is as good as the delayed phase to diagnose cardiac amyloidosis

    Page :30

    A. Galat, A. Van Der Gucht, A. Guellich, D. Bodez, S. Guendouz, A.S. Cottereau, L. Hittinger, J.L. Dubois-Randé, V. Planté, E. Itti, M. Meignan, T. Damy, J. Rosso

    
  • ·Interest of a systematic investigation when a Tako Tsubo Syndrome is suspected

    Page :30-31

    L. Marty, C. Delmas, C. Biendel, M. Elbaz, D. Carrie, M. Galinier, O. Lairez

    Résumé Résumé Plan Plan
  • ·Evidence for genetic heterogeneity in left ventricle non compaction by next generation sequencing of 110 genes in 95 unrelated patients

    Page :31

    P. Richard, F. Ader, M. Roux, N. Aoutil, C. Lavoute, D.A. Tregouet, G. Habib, P. Charron

    
  • ·Association between mutation size and cardiac involvement in myotonic dystrophy type 1: when size matters

    Page :31-32

    C. Chong-Nguyen, K. Wahbi, V. Algalarrondo, H.M. Bécane, H. Radvanyi-Hoffman, P. Arnaud, D. Furling, G. Bassez, A. Lazarus, P. Laforet, T. Stojkovic, A. Behin, A. Fayssoil, B. Eymard, D. Duboc

    Résumé Résumé Plan Plan
  • ·Prognostic value of echocardiographic right ventricular parameters on arrhythmogenic right ventricular cardiomyopathy

    Page :32

    A. Zaroui, M.F. Drissi, H. Zargouni, R. Mechmeche

    
  • ·Impact of the localization of late gadolinium enhancement on the initial cardiac MR in patients with acute myocarditis

    Page :32

    M. Carre, S. Tisserand, O. Humbert, K. Stamboul, A. Cochet, Y. Cottin

    
  • ·The impact of diurnal fasting during Ramadan on the lipid profile in patients with chronic heart failure

    Page :32

    F. Haloui, N. Elazaoui, K. Kharbouche, R. Habbal

    
  • ·Is there a white-coat effect for heart rate in heart failure? Characteristics and prognostic implications in patients with idiopathic dilated cardiomyopathy

    Page :32-33

    L. Fauchier, B. Lequeux, A. Bisson, M. Boyer, B. Pierre, D. Angoulvant, N. Clementy, D. Babuty

    Résumé Résumé Plan Plan
  • ·Results of a single center experience on 110 consecutive patients treated with Entresto (sacubitril/valsartan)

    Page :33

    A. Canu, M. Hebert, A. Gachet, F. Arabucki, V. Maurin, F. Picard, P. Dos Santos

    
  • ·Description of the GP practices in optimizing chronic heart failure treatment after hospital discharge: current state and perspectives

    Page :33

    S. M’sadek, J. Diarova, M.P. Gandolfini, D. Sauvion, J. Beloued, M. Aousji, F. Digne, L. Krapf

    
  • ·Quality of life in outpatients with hypertrophic cardiomyopathy

    Page :34

    M. Jacquelinet, A. Duva Pentiah, A. Coisne, P. Lapierre, E. Hebbar, M. Fertin, H. Ridon, D. Montaigne, N. Lamblin, P. De Groote

    
  • ·Prognostic significance of heart rate in patients with chronic heart failure with reduced ejection fraction

    Page :34

    A. Asadi, F. Arhlade, R. Habbal

    
  • ·Epidemiological, clinical and etiological study of acute heart failure on a ten year period (2005-2014) in cardiology department of hospital Issas Hassani of Algiers

    Page :34

    F. Belamri, K. Oumokrane

    
  • ·Impact of social deprivation on heart failure and risk of early readmission after hospitalization for acute heart failure

    Page :34-35

    D. Inzouddine, H. Ba, V. Gardan, A. Valla, L. Tartière-Kesri, J. Tartière

    Résumé Résumé Plan Plan
  • ·The influence of female gender on the outcomes of heart failure with diabetes

    Page :35

    F. Haloui, K. Kharbouche, R. Habbal

    
  • ·Young vs adults heart failure, are there real differences?

    Page :35

    K. Kharbouche, G. Mohssine, I. Elhaddad, L. Azzouzi, R. Habbal

    
  • ·Rehospitalization for heart failure at the university hospital center of Brazzaville

    Page :35

    B. Ellenga Mbolla, G. Ongagna, S.G. Mongo Née Ngamami, C. Kouala Landa, M.S. Ikama, T.R. Gombet, S.G. Kimbally Née Kaky

    
  • ·The prevalence and characteristics of pulmonary hypertension and its prognosis value in chronic systolic heart failure: about 30106 cases from the Ibn Rochd-HF registry

    Page :36

    F. Sabri, M. Abelhad, R. Habbal

    
  • ·Precipitating factors of cardiac decompensation in an African cardiological setting in patients suffering of heart failure

    Page :36

    I. Coulibaly, D. Bamba, E. Soya, M. Zoumenou

    
  • ·OBLIC: a nationwide French prospective cohort of heart failure ambulatory patients managed in private practice

    Page :36

    F. Mouquet, D. Guedj-Meynier, G. Godin, T. Beard, M. Raphael, D. Attias, P. Tessier, P. Gueranger, L. Brottier, M. Abichacra, A. Warembourg, O. Hoffman, J.P. Huberman, J. Gauthier, A. Cohen Solal

    
  • ·Predicting mortality in heart failure: derivation of a simple mortality risk score in French outpatients

    Page :36-37

    K. Solecki, C. Duflos, G. Mercier, F. Roubille

    Résumé Résumé Plan Plan
  • ·Morbidity and mortality of chronic heart failure (CHF) patients with central sleep apnoea (CSA) treated by adaptive servoventilation (ASV): interim results of FACE cohort study

    Page :37

    T. Damy, R. Tamisier, J.L. Pepin, P. Levy, L. Morin, M.P. D’ortho, J.M. Davy

    
  • ·Cardiac dysfunction is the main mechanism of aggravation of exercise intolerance in homozygous sickle cell disease patients

    Page :37-38

    A. Ceccaldi, R. Isnard, K. Stankovic Stojanovic, F. Lionnet, S. Hatem, N. Hammoudi

    Résumé Résumé Plan Plan
  • ·Modalities and therapeutic impact of a standardized management in a cardio-oncology unit

    Page :38

    C. Ammar, J. Cautela, M. Orabona, M. Peyrol, J. Barraud, M. Laine, L. Bonello, F. Barlesi, F. Paganelli, F. Thuny

    
  • ·Cardiovascular monitoring and management in cancer patients: a French regional survey

    Page :38-39

    L. Jovenaux, J. Cautela, M. Orabona, M. Peyrol, P. Debourdeau, D. Serin, Y. Le Dolley, N. Michel, J. Barraud, M. Laine, L. Bonello, F. Paganelli, F. Barlesi, F. Thuny

    Résumé Résumé Plan Plan
  • ·News parameters for early diagnosis of anthracycline induced cardiotoxicity in children

    Page :39

    L. Dimitriu, A. Dimitriu

    
  • ·Pre- and in-hospital course of care for patients with acute heart failure: features and impact on prognosis in the real life

    Page :39

    L. Cluzol, J. Cautela, P. Michelet, A. Roch, F. Kerbaul, J. Mancini, M. Laine, M. Peyrol, F. Robin, L. Bonello, F. Paganelli, F. Thuny

    
  • ·Furosemide doses and long-term mortality after discharge from heart failure episode: the FACT – HF study

    Page :39-40

    J. Costa, L. Simone, V. Héroguelle, P. Nazeyrollas, D. Metz

    Résumé Résumé Plan Plan
  • ·Severe right ventricular dysfunction is a strong predictor of pre and post-transplant mortality among candidates to heart transplantation

    Page :40

    E. Ravis, A. Theron, J. Mancini, N. Jaussaud, P. Morera, V. Chalvignac, D. Grisoli, V. Gariboldi, A. Riberi, G. Habib, A. Mouly-Bandini, F. Collart

    
  • ·Management of heart failure patients by nurse practitioners specialized in cardiology

    Page :41-42

    S. Béchard, M.L. Brouillette, N. Nadon, S. Argentin, F. Tournoux

    Résumé Résumé Plan Plan
  • ·Cardiac involvement in the newborn of diabetic mother. Usefulness of echocardiographic assessment

    Page :42

    Lavinia Dimitriu, A. Dimitriu

    
  • ·Correlation between metabolic syndrome and severity of vessel coronary disease in ischemic heart failure

    Page :42

    F. Arhlade, R. Habbal

    
  • ·A novel myocardial fibrosis risk score in heart failure with preserved ejection fraction

    Page :42

    A. Secq, J.N. Dacher, V. Richard, V. Brunel, C. Vallet, H. Eltchaninoff, F. Bauer

    
  • ·Echocardiographic analysis in hypertrophic cardiomyopathy: the left atrial function as a predictive of left ventricular diastolic dysfunction and a worsening functional status

    Page :42-43

    S. Charfeddine, L. Abid, A. Feki, D. Abid, S. Kammoun

    Résumé Résumé Plan Plan
  • ·Echographic characteristics of PH in HFpEF and precapillary PH

    Page :43

    E. Berthelot, S. El Hatimi, M.T. Bailly, I. Robard, O. Sitbon, P. Assayag

    
  • ·Magnetic resonance imaging as the first line imaging in left ventricular dysfunction: evaluation on 305 patients

    Page :43

    L. Desroche, B. Safar, O. Milleron, P. Ou, E. Garbarz, Y. Lavie Badie, J. Abtan, D. Millischer, G. Jondeau

    
  • ·Correlation between right ventricular function and exercise capacity in patients with chronic heart failure

    Page :43-44

    B. Herbegue, S. Chenik, S. Antit, I. Slama, B. Hamrouni, L. Zakhama, S. Benyoussef

    Résumé Résumé Plan Plan
  • ·The genetic contribution in the evaluation of cardiac patients in a non-university hospital

    Page :44

    H. Ba, P. Collignon, D. Inzouddine, L. Tartière-Kesri, J. Tartière

    
  • ·Cardiac involvements in scleroderma Algerian patients

    Page :44

    N. Methia, S. Latreche, N. Smail, S. Benkhedda

    
  • ·Right ventricule systolic and diastolic function in patients with endstage renal disease

    Page :44

    K. Kharbouche, A. Jebli, A. Ramdani, R. Habbal

    
  • ·Prognostic role of tricuspid annular plane systolic excursion in chronic heart failure

    Page :44-45

    B. Herbegue, S. Chenik, S. Antit, I. Slama, B. Hamrouni, L. Zakhama, S. Benyoussef

    Résumé Résumé Plan Plan

• Topic 03 - Echocardiography and imaging

  • ·Prognostic value of parameters of right ventricular and pulmonary artery function in patients with pulmonary hypertension receiving specific vasodilator therapy

    Page :46

    C. Ginghina, R. Enache, E. Popa, R.O. Jurcut, I.M. Coman, B.A. Popescu

    
  • ·External validation of right heart failure risk scores following LVAD implantation and evaluation of emerging echocardiographic indices

    Page :46

    M. Aymami, F. Haddad, M. Amsallem, M. Marques, K. Sallam, M. Wheeler, J. Adams, S. Zeigler, J. Woo, R. Ha, D. Banerjee

    
  • ·New three-dimensional echocardiography method to quantify aortic valve calcification

    Page :46-47

    L. Faivre, T. D’humières, E. Chammous, J.L. Dubois-Randé, J.L. Monin, P. Lim, J. Ternacle

    Résumé Résumé Plan Plan
  • ·New indices for a best quantification of left ventricular function in heart valve diseases

    Page :47

    A. Hubert, E. Galli, G. Bouzille, E. Samset, E. Donal

    
  • ·Validation of ultrafast imaging for intra-ventricular vortex assessment

    Page :47-48

    J. Faurie, M. Baudet, D. Auger, D. Garcia, F. Tournoux

    Résumé Résumé Plan Plan
  • ·Cardiac magnetic resonance evaluation of cardiac thrombi and masses by T1 and T2 mapping: a preliminary observational study

    Page :48

    T. Caspar, S. El Ghannudi, P. Ohlmann, A. Lawson, O. Morel, M. Ohana, C. Roy, A. Gangi, P. Germain

    
  • ·High diagnostic performances of ⁸²Rubidium-PET for the detection of coronary artery disease as compared to ⁹⁹Tc-MIBI with CZT gamma cameras in a population of overweighed patients and women

    Page :48-49

    F. Hyafil, R. Chequer, E. Sorbets, C. Estellat, F. Rouzet, G. Ducrocq, J. Abtan, A. Touati, T. Alfaiate, S. Leygnac, M. Milliner, R. Ben Azzouna, A. Hartemann, R. Roussel, G. Montalescot, P.Y. Marie, D. Le Guludec

    Résumé Résumé Plan Plan
  • ·Area at risk assessed by ¹²³I-MIBG SPECT: prospective study in 35 patients admitted for acute STEMI and comparison to cardiac magnetic resonance

    Page :49

    C. Hedon, F. Huet, H. Vernhet, D. Mariano-Goulart, B. Lattuca, F. Roubille

    
  • ·Echocardiography in pulmonary hypertension due to left heart disease: a focus on the right heart changes in patients with hypertensive heart disease at the Douala General Hospital, Cameroon

    Page :49-50

    M. Hongieh Abanda, A. Dzudie, L.N. Aminde, F. Kamdem, B. Dzekem

    Résumé Résumé Plan Plan
  • ·Subepicardial hyperemia on contrast-enhanced first-pass magnetic resonance perfusion imaging is useful for the diagnosis of acute myocarditis

    Page :50

    S. Zarka, C. Bouleti, D. Arangalage, H. Chopra, P.G. Steg, A. Vahanian, J.P. Laissy, P. Ou

    
  • ·Left atrial strain as a predictive factor of new-onset silent atrial fibrillation after acute myocardial infarction

    Page :50

    A. Rothe, K. Stamboul, L. Fauchier, J.C. Eicher, E. Noirot, R. Robert, M. Maza, M. Zeller, Y. Cottin

    
  • ·Imaging study of the right ventricular function on dilated myocardiopathy: value of the global longitudinal strain

    Page :50

    A. Zaroui, A. Zidi, H. Zargouni, M.F. Drissi, R. Mechmeche

    
  • ·Problems of diagnosis of cardiac involvement in malignant lymphoma in children

    Page :50-51

    A. Dimitriu, I. Miron, L. Dimitriu

    Résumé Résumé Plan Plan
  • ·Impact of obstructive sleep apnea on global left ventricular myocardial performance

    Page :51

    B. Herbegue, S. Chenik, S. Antit, I. Slama, B. Hamrouni, L. Zakhama, S. Benyoussef

    
  • ·Prognostic impact of thrombus burden as evaluated by OCT in patients with non-ST elevation acute coronary syndromes undergoing PCI

    Page :51

    N. Braik, M. Chatot, B. Bonnet, F. Ecarnot, R. Chopard, M. Badoz, M.F. Seronde, F. Schiele, N. Meneveau

    
  • ·Feasibility, image quality and radiation dose of coronary CT angiography (CCTA) in patients with atrial fibrillation using a new generation 256 Multi-Detector CT (MDCT)

    Page :51-52

    Z.M. Bensalah, M. Bendeddouche, F. Targosz, G. Nadji, J.L. Bertrand

    Résumé Résumé Plan Plan
  • ·Long-term follow up myocardial deformation in patients with myotonic dystrophy type 1

    Page :52

    C. Goujeau, B. Degand, F. Le Gal, R. Garcia, L.P. Christiaens

    
  • ·Noninvasive measurement of the product pulmonary Resistance x Capacitance by MRI

    Page :52

    L. Bonnemains, A. Guillou, D. Voilliot, F. Chabot, P.Y. Marie, J. Felblinger

    
  • ·Prognostic impact of tissue prolapse after stent implantation in patients with non-ST elevation acute coronary syndromes: an optical coherence tomography study

    Page :53

    B. Bonnet, N. Braik, M. Chatot, J. Huang, R. Chopard, F. Schiele, N. Meneveau

    
  • ·Possible role of microvascular dysfunction in the weak association found between stress myocardial blood flow measured with ⁸²Rubidium-PET and FFR values measured during coronary angiography

    Page :53

    E. Sorbets, R. Chequer, G. Ducrocq, J. Abtan, A. Touati, F. Rouzet, H. Regaieg, S. Leygnac, R. Ben Azzouna, M. Milliner, P.Y. Marie, G. Montalescot, D. Le Guludec, F. Hyafil

    
  • ·First-pass perfusion imaging to improve the assessment of left ventricular thrombus following a myocardial infarction

    Page :53

    L. Bière, M. Audonnet, G. Clerfond, H. Delagarde, S. Willoteaux, F. Prunier, A. Furber

    
  • ·Measurements by CT angiography of the left atrial appendage before percutaneous closure with a watchman device

    Page :53-54

    G. Bonnet, E. Salaun, S. Deffarges, M. Pankert, T. Cuisset, J. Bonnet

    Résumé Résumé Plan Plan
  • ·Ability of^99mTc-DPD scintigraphy to predict conduction disorders requiring permanent pacemaker in patients with transthyretin-related cardiac amyloidosis

    Page :54

    S. Brun, S. Pradel, P. Mondoly, G. Victor, D. Ribes, P. Pascal, M. Galinier, D. Carrié, P. Maury, I. Berry, A. Duparc, O. Lairez

    
  • ·2D-speckle tracking right ventricular strain to assess right ventricular systolic function in left ventricular systolic dysfonctiun: analysis of the right ventricular free and inferior walls

    Page :54

    S. Mouton, H. Ridon, M. Fertin, A. Duva Pentiah, C. Goemine, G. Petyt, A. Coisne, N. Lamblin, D. Montaigne, P. De Groote

    
  • ·Impact of negative inotropic drugs on echocardiographic evaluation of left ventricular filling pressure in patients with normal left ventricular ejection fraction during exercise stress test

    Page :55

    J. Salem, F. Laveau, N. Hammoudi

    
  • ·Could stress perfusion MRI and T1 mapping study detect earlier than exercise stress echocardiography predictor factors of clinical outcome in patients with hypertrophic cardiomyopathy?

    Page :55

    M. Berous, H. Vernhet-Kovacsik, F. Cransac, M. Verges, T. Cung, N. Molinari, S. Cade

    
  • ·Physiopathological determinants of secondary mitral regurgitation in patients with aortic stenosis and preserved ejection fraction

    Page :55

    B. Bantu Bimbi, L. Jahjah, J.L. Vandenbossche, P. Unger

    
  • ·Late detection of left ventricular dysfunction using 2D and 3D speckle-tracking echocardiography in patients with history of nonsevere acute myocarditis

    Page :56

    T. Caspar, M. Fichot, H. Samet, H. Petit-Eisenmann, A. Trinh, S. Talha, L. Jesel, M. Ohana, S. El Ghannudi, O. Morel, P. Ohlmann

    
  • ·Assessment of the positive work and mechanical dispersion: new methods to quantify left ventricular function in aortic stenosis

    Page :56

    A. Hubert, E. Galli, G. Bouzille, E. Samset, E. Donal

    
  • ·Three-Dimensional speckle tracking of the right ventricle: implications on survival

    Page :56-57

    P. Moceri, N. Duchateau, D. Baudouy, E.D. Schouver, P. Bouvier, S. Leroy, P. Cerboni, P. Gibelin, M. Sermesant, E. Ferrari

    Résumé Résumé Plan Plan
  • ·Performing transesophageal echocardiography in infants remains a challenge

    Page :57

    K. Hadeed, R. Amadieu, N. Tahhan, Y. Dulac, G. Chausseray, R. Fesseau, P. Cuttone, X. Alacoque, B. Leobon, P. Acar

    
  • ·Effect of changing the preload on speckle-tracking-derived left ventricular contractility indexes in middle-aged ultra-trailers

    Page :57-58

    F. Chagué, A. Gudjoncik, C. Richard, F. Compagnon, O. Ganansia, V. Pasquereau, Y. Cottin

    Résumé Résumé Plan Plan

• Topic 04 - Valvular heart disease and general cardiology

  • ·Impact of the permanent pacemaker implantation on 3-year mortality after transcatheter aortic valve implantation

    Page :59

    J. Corré, O. Bar, C. Barbey, S. Chassaing, D. Chatel, O. Lepage, M.A. Arnould, D. Blanchard

    
  • ·Incidence, predictors and impact of readmission for heart failure after transcatheter aortic valve implantation

    Page :59

    E. Durand, M. Doutriaux, M. Dupré, A. Bizios, N. Bettinger, C. Tron, B. Glinel-Mortreuil, F. Bauer, H. Eltchaninoff

    
  • ·Safety and effectiveness of transsubclavian approach for TAVI: a single-center experience

    Page :59-60

    F. Giardinelli, A. Anselmi, H. Le Breton, V.G. Ruggieri, A. Armenise, A. Roisne, J.P. Verhoye

    Résumé Résumé Plan Plan
  • ·Feasibility and safety of Sapien 3 TAVR in intermediate-risk patients

    Page :60

    B. Alhabil, A. Dibie, C. Caussin

    
  • ·Rescue percutaneous balloon aortic valvuloplasty in patients with aortic stenosis and severe acute heart failure

    Page :60

    M. Eugène, M. Urena-Alcazar, D. Himbert

    
  • ·Immediate benefit of balloon aortic valvuloplasty in low flow aortic stenosis: hemodynamic echographic assessment in coronary care unit

    Page :60-61

    M. Calcaianu, H. Kremer, N. Messas, F. Zeyons, U. Crimizade, M. Kindo, P. Attali, S. Hess, O. Morel, P. Ohlmann

    Résumé Résumé Plan Plan
  • ·Cardiopulmonary exercise testing is a better outcome predictor than exercise echocardiography in asymptomatic aortic stenosis

    Page :61

    O. Domanski, M. Richardson, A. Coisne, A.S. Polge, S. Mouton, D. Montaigne

    
  • ·Influence of metabolic syndrome on progression of calcific aortic valve stenosis – the COFRASA – GENERAC study

    Page :61

    A. Testuz, V. Nguyen, T. Mathieu, C. Kerneis, N. Kubota, I. Codogno, A. Vahanian, D. Messika-Zeitoun

    
  • ·Influence of fetunin-A level on progression of calcific aortic valve stenosis – the COFRASA – GENERAC Study

    Page :62

    A. Testuz, N. Kubota, V. Nguyen, T. Mathieu, C. Kerneis, I. Codogno, A. Vahanian, D. Messika-Zeitoun

    
  • ·Prognostic impact of pulmonary endarterectomy national expertise in patients with chronic thromboembolic pulmonary hypertension: results from a single regional cohort

    Page :62

    J. Pradier, S. Renard, M. Nicolas, R. Giorgi, J. Haentjens, G. Habib

    
  • ·Should diuretic first attempted in patients with severe secondary tricuspid regurgitation?

    Page :62

    H. Doan, L. Oliver, T. D’Humières, L. Faivre, J.L. Monin, J.L. Dubois Randé, P. Lim, J. Ternacle

    
  • ·Does tricuspid annuloplasty increases surgical mortality and morbidity during mitral valve replacement?

    Page :62-63

    A. Darmon, C. Verdonk, L. Lepage, C. Cimadevilla, P. Nataf, A. Vahanian, D. Messika-Zeitoun

    Résumé Résumé Plan Plan
  • ·Thirty-day and long-term outcomes after transcatheter aortic valve implantation from first-in-man to Sapien 3: 14 years Rouen experience

    Page :63

    G. Avinee, E. Durand, C. Tron, A. Bizios, N. Bettinger, F. Bauer, B. Glinel, P.Y. Litzler, J.P. Bessou, A. Cribier, H. Eltchaninoff

    
  • ·Should we give anticoagulants to all patients implanted with transcatheter aortic valves?

    Page :63-64

    F. Huchet, V. Letocart, P. Guerin, J.C. Roussel, C. Cueff, J. Roy, P. Jaafar, T. Manigold

    Résumé Résumé Plan Plan
  • ·Suprasternal brachiocephalic approach as an alternative route for transcatheter aortic valve implantation: a single-center experience

    Page :64

    G. Capretti, M. Urena, D. Himbert, W. Ghodbane, C.G. Verdonk, C. Goublaire, S. Alkhoder, R. Raffoul, J.L. Carrasco, M. Laredo, P. Nataf, A. Vahanian

    
  • ·Prognostic value of NT pro-BNP levels on mild to long term outcome after TAVI: a monocentric study

    Page :65

    G. Gouffran, D. Blanchard, S. Chassaing, O. Bar, C. Barbey, M.A. Arnould, O. Lepage, D. Chatel

    
  • ·Mitral regurgitation etiology affects outcomes in high risk or inoperable patients undergoing transcatheter aortic valve implantation for severe aortic stenosis

    Page :65-66

    E. Ouzan, B. Kindya, E. Gonen, S. Lerakis, I. Gotsman, V. Thourani, E. Karayel, B. Leshnower, R. Beeri, P. Block, D. Gilon, R. Guyton, H. Danenberg, V. Babaliaros, C. Lotan, K. Mavromatis

    Résumé Résumé Plan Plan
  • ·What causes mitral annulus dilatation. A three dimensional study

    Page :66

    V. Boileve, J. Dreyfus, D. Attias, I. Codogno, E. Brochet, A. Vahanian, D. Messika-Zeitoun

    
  • ·The impact of functional mitral valve regurgitation in 1600 patients with chronic heart failure

    Page :66

    K. Kharbouche, L. Azzouzi, R. Habbal

    
  • ·Eclipsed mitral regurgitation: a new entity responsible for acute heart failure in patients with preserved left ventricular ejection fraction

    Page :67

    O. Milleron, C. Bouleti, S. Mazouz, E. Brochet, F. Rouzet, P. Nataf, W. Ghobdane, D. Messika-Zeitoun, M.P. Dilly, S. Cattan, A. Vahanian, B. Iung, G. Jondeau

    
  • ·Redo percutaneous mitral commissurotomy interventions for mitral stenosis: immediate and one-year results compared to a primary procedure. A prospective observational study between 2010 and 2015

    Page :67

    C. Perron, E. Salaün, G. Bonnet, N. Resseguier, J.P. Mouret, J. Bonnet

    
  • ·Evaluation of automatic software to select aortic bioprosthesis before transcatheter aortic valve implantation

    Page :67

    M. Dupré, E. Durand, A. Abisror, S. Le Couteulx, C. Tron, A. Bizios, F. Bauer, B. Glinel Mortreuil, J.N. Dacher, H. Eltchaninoff

    
  • ·Treatment of degenerated self-expandable sutureless aortic prostheses with transcatheter valve implantation: a pilot series

    Page :67-68

    N. Amabile, K. Zannis, A. Veugeois, A. Dibie, F. Philippe, C. Caussin

    Résumé Résumé Plan Plan
  • ·Percutaneous closure of left atrial appendage with a watchman device: a single center study

    Page :68

    G. Bonnet, E. Salaun, S. Deffarges, J. Mouret, T. Cuisset, J. Bonnet

    
  • ·Cardiac computed tomography angiography is helpful to select patients for left atrial appendage occlusion with a watchman device

    Page :68

    G. Bonnet, E. Salaun, S. Deffarges, T. Cuisset, J. Bonnet

    
  • ·Predictors of successful percutaneous mitral balloon commissurotomy in patients with severe mitral stenosis

    Page :68-69

    S. Charfeddine, L. Abid, A. Tounsi, F. Triki, R. Hammami, M. Hentati, D. Abid, S. Kammoun

    Résumé Résumé Plan Plan
  • ·Impact of commissural calcification on the immediate result of percutaneous mitral commissurotomy

    Page :69

    L. Bezdah, E. Allouche, S. Sidhom, H. Boussaid, N. Hammami, H. Ben Ahmed, W. Ouchtati, H. Baccar

    
  • ·Functional results after percutaneous mitral valvuloplasty in a series of 350 procedures and analysis of predictive factors

    Page :69

    S. Milouchi, O. Abid, H. Ajmi, S. Ferjani

    
  • ·Can significant mitral stenosis be a cause of paradoxical low gradient, low flow in patients with severe aortic stenosis? An echocardiographic and outcome study

    Page :69-70

    A. Soufiani, H. Ougnou, F.Z. Elhattab, N. Bendagha, L. Mahfoudi, F. Lachhab, M. Tribak, S. Moughil, D. Mohty

    Résumé Résumé Plan Plan
  • ·Percutaneous mitral commissurotomy in the pregnant woman

    Page :70

    K. Kharbouche, J. Hassari, L. Azzouzi, R. Habbal

    
  • ·Rheumatic mitral valve stenosis: frequency, clinical characteristics and management: Moroccan experience

    Page :70

    K. Kharbouche, J. Hassari, L. Azzouzi, R. Habbal

    
  • ·Predictors of thromboembolic complication of mitral stenosis occurred in sinus rhythm

    Page :70

    K. Kharbouche, J. Hassari, I. Elhaddad, L. Azzouzi, R. Habbal

    
  • ·Maternal and fetal complications in pregnant women with mitral valve stenosis

    Page :70-71

    N. Benatta, D.D. Batouche

    Résumé Résumé Plan Plan
  • ·Echocardiographic parameters of heart failure in the patients with rheumatic mitral stenosis and arterial hypertension

    Page :71

    K. Kharbouche, S. Benhaourech, J. Hassari, L. Azzouzi, R. Habbal

    
  • ·Natural history of borderline rheumatic heart disease in New Caledonia: a prospective cohort study

    Page :87

    G. Bertaina, B. Rouchon, B. Huon, N. Guillot, C. Robillard, B. Noel, M. Nadra, C. Tribouilloy, E. Marijon, X. Jouven, M. Mirabel

    
  • ·The new epidemiological model for rheumatic heart disease: from subclinical to symptomatic disease

    Page :71-72

    M. Mirabel, M. Tafflet, B. Noel, C. Braunstein, M. Nadra, B. Rouchon, E. Marijon, X. Jouven

    Résumé Résumé Plan Plan
  • ·Tricuspid valve disease associated to rheumatic left valve disease: 1002 cases single-center study

    Page :72

    H. Bennani, Y. Moutaki Allah, S. Ratbi, I. Asfalou, M. Ait Houssa

    
  • ·Prediction of systemic septic embolism in patients with left-sided infective endocarditis

    Page :72

    L. Fauchier, L. Pericart, A. Bernard, L. Bernard, N. Clementy, T. Bourguignon, A. Bisson, F. Dion, D. Angoulvant, D. Babuty

    
  • ·Is that the profile of infective endocarditis has changed in Tunisia?

    Page :72-73

    M. Drissa, M. Cheour, S. Kaabachi, F. Yahia, H. Drissa

    Résumé Résumé Plan Plan
  • ·Review of 49 cases of infective endocarditis in Tunisian public hospital

    Page :73

    W. Ouechtati ben Attia, S. Helali, M. Kharroubi, E. Allouche, L. Bezdeh, H. Baccar

    
  • ·Cause of death in patients with Marfan syndrome

    Page :73

    D. Baghdadi, O. Milleron, M. Langeois, M. Spentchian, F. Arnoult, G. Delorme, G. Jondeau

    
  • ·Aortic dissection in Marfan syndrome: is bicuspid aortic valve (BAV) a risk factor?

    Page :74

    O. Milleron, D. Baghdadi, M. Langeois, M. Spentchian, F. Arnoult, G. Delorme, G. Jondeau

    
  • ·Impact on survival of the severity in aortic stenosis in initially non operated patients

    Page :74

    K. Marcovitch, E. Schröder, B. Bihin, B. Marchandise, S. Seldrum, M. Gérard, A. Guédès, L. Gabriel, V. Dangoisse, C. Hanet, M. Buche

    
  • ·Quality control assessment in cardiac surgery: single center experience in aortic valve replacement by mechanical prosthesis

    Page :74

    L. Guillaume, E. Schröder, B. Bihin, I. Michaux, A. Dive, C. Hanet, A. Guédès, V. Dangoisse, L. Gabriel, S. Seldrum, M. Gérard, P.H. Eucher, Y. Louagie, M. Buche

    
  • ·Rationalization of complementary tests in cardiology department

    Page :75

    J. Corré, P. Poustis, G. Bonnet, P. Robino, C.M. Anthierens, M. Faure, H. Douard

    
  • ·Can methylphenidate induce cardiac arrhythmias? A pharmacoepidemiological study

    Page :75

    F. Montastruc, S. Fregevu, G. Montastruc

    
  • ·Cardiovascular involvement in systemic lupus erythematosus

    Page :75

    M. Kechida, R. Klii, S. Arfa, W. Jomaa, K. Ben Hamda, F. Maatouk, S. Hammami, I. Khochtali

    
  • ·Anticoagulation’s problematic during pregnancy in carriers of mechanical heart prostheses

    Page :75-76

    N. Benatta, D.D. Batouche

    Résumé Résumé Plan Plan

• Topic 05 - Rhythmology and stimulation

  • ·Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death

    Page :77

    S. Boulé, M. Sémichon, L. Guédon-Moreau, E. Drumez, C. Kouakam, C. Marquié, F. Brigadeau, C. Potelle, W. Escande, Z. Souissi, D. Lacroix, D. Klug

    
  • ·ICD implantion for primary SCD prevention in the era of economic crisis

    Page :77

    A. Manolis, K. Kouvelas, G. Manolis, C. Maniotis, D. Oikonomidis

    
  • ·Inappropriate therapies from the subcutaneous ICD: single center experience from 38 patients

    Page :77-78

    P. Jacon, S. Venier, A. Tabane, F. Dugenet, P. Defaye

    Résumé Résumé Plan Plan
  • ·S-ICDs in adults with complex congenital heart diseases and absence of venous access to the heart

    Page :78

    R. El Bouazzaoui, C. Marquie, G. Bertaux, M. Chauvin, C. Bredy, M. Massin, D. Klug, J.L. Pasquie

    
  • ·Appropriate and inappropriate shock rates in a population followed by remote monitoring in a retrospective monocentric study

    Page :78

    M. Bouygues, P. Jacon, P. Defaye

    
  • ·Safety of device implantation under antipatelet therapy with ticagrelor: about 20 cases

    Page :78

    W. Amara, S. Naccache, C. Akret, S. Cheggour, S. M’zoughi, G. Galuscan, A. Dompnier

    
  • ·Routine pacemaker primoimplantation procedures in France: the French Electra survey

    Page :79

    J. Taieb, M. Genoun, J. Mansourati, J. Cebron, F. Fossati, A. Lazarus

    
  • ·Statistics on the use of cardiac electronic devices and electrophysiological procedures from 2011 to 2014 in 27 African countries: first report from the Pan African Society of Cardiology (PASCAR)

    Page :79

    A. Bonny, E. Okello, M. Ngantcha, K. Bundhoo, K. Tibazarwa, A. Chin, A. Kane, A. Dzudie, K. Karaye, M.A. Talle, M. Ouankou

    
  • ·Transvenous extraction of more than 1200 pacemaker and defibrillator leads between 2003 and 2013: prognostic factors of morbidity and mortality

    Page :79

    C. Seunes, C. Marquie, Z. Souissi, J.B. Dally, A. Coisne, G. Fayad, D. Lacroix, D. Klug

    
  • ·Device-detected silent atrial fibrillation is associated to a high hospitalization rate for heart failure

    Page :80

    R. El Bouazzaoui, J. Davy, F. Massin, T.T. Cung, Z. Khoueiry, S. Thomann, J.L. Pasquie

    
  • ·Shall we implant a pacemaker only in case of complete atrioventricular block following TAVI? Quantification of ventricular pacing percentage according to pacemaker indication

    Page :80

    A. Mirolo, A. Savouré, B. Godin-Gardea, N. Auquier, G. Viart, E. Durand, C. Tron, N. Bouhzam, F. Bauer, O. Raitière, H. Eltchaninoff, F. Anselme

    
  • ·Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis

    Page :80-81

    D. Hamon, V. Algalarrondo, E. Gandjbakhch, F. Extramiana, E. Marijon, N. Elbaz, D. Selhane, J.L. Dubois-Rande, E. Teiger, V. Plante-Bordeneuve, T. Damy, N. Lellouche

    Résumé Résumé Plan Plan
  • ·Electrical storms in patients with implantable cardioverter-defibrillators implanted for secondary prophylaxis indications: incidence, features, predictors and impact on mortality

    Page :81

    S. Boulé, M. Sémichon, L. Guédon-Moreau, E. Drumez, C. Kouakam, C. Marquié, F. Brigadeau, C. Potelle, W. Escande, Z. Souissi, D. Lacroix, D. Klug

    
  • ·Paroxysmal atrial fibrillation ablation using the second-generation cryoballoon catheter without “bonus” application: one year follow-up

    Page :81

    C. Alarcon, N. Auquier, B. Godin, A. Savoure, B. Glinel, R. Breil, H. Eltchaninoff, F. Anselme

    
  • ·Hybrid treatment of persistent atrial fibrillation: combined epicardial and endocardial ablation

    Page :82

    A. Rollin, B. Marcheix, P. Mondoly, A. Duparc, C. Cardin, P. Maury, E. Grunenwald

    
  • ·Automated ultra-high definition mapping of iatrogenic scar-related atrial arrhythmias allows successful ablation without need for entrainment mapping

    Page :82

    D. Latcu, S. Bun, F. Viera, T. Delassi, A. Alamourh, N. Saoudi

    
  • ·Is adherence to non AVK therapy improved by a personnalized information program? A first look to MONACO study

    Page :82

    J. Davy, Z. Khoueiry, T.T. Cung, F. Massin, F. Cransac, J.L. Pasquié, F. Roubille

    
  • ·Correlation between CHA2DS2-VASc score and size of the left atrium in non valvular atrial fibrillation

    Page :82-83

    B. Herbegue, S. Chenik, S. Antit, I. Slama, B. Hamrouni, L. Zakhama, S. Benyoussef

    Résumé Résumé Plan Plan
  • ·Assessment of the quality of chronic anticoagulation control with time in therapeutic range in atrial fibrillation patients treated with acenocumarol

    Page :83

    S. Ouali, M. Mechri, Z. Ben Ali, M. Ben Halima, S. Boudiche, N. Khedher, H. Aloui, F. Zghal, N. Larbi, A. Farhati, M.S. Mourali

    
  • ·One-year permeability rate of LAA closure devices: high incidence of peridevice leak and lack of endothelialization

    Page :83

    G. Laugaudin, M. Granier, F. Massin, S. Cade, F. Cransac, J.E. Ricci, C. Freitag, H. Vernhet-Kovacsik, J.L. Pasquie

    
  • ·Validation of the SAMe-TT2R2 score in a North African population of nonvalvular atrial fibrillation patients on acenocumarol

    Page :83-84

    S. Ouali, M. Mechri, Z. Ben Ali, M. Ben Halima, S. Boudiche, N. Khedher, H. Aloui, N. Larbi, F. Zghal, A. Farhati, M.S. Mourali

    Résumé Résumé Plan Plan
  • ·Electrocardiographic modifications induced by breasts implants

    Page :84

    S. Bun, D.G. Latcu, T. Delassi, A. Al Amoura, N. Saoudi

    
  • ·Long-term prognostic significance of exercise-induced right bundlebranch ventricular ectopy

    Page :84

    L. Bière, T.H. Mezdad, J.M. Dupuis, L. Vervueren, H. Rakotonirina, F. Prunier, A. Furber

    
  • ·QTc and Tpeak-Tend dispersion prolongations following ablation of atrial fibrillation

    Page :84-85

    M. Blaye-Felice Sadron, B. Mokrani, L. Roten, F. Garnier, J. Laaouaj, E. Gitenay, J.F. Sarrazin, J. Champagne, G. O’hara, F. Philippon, L. Blier, F. Molin, M. Haissaguerre, I. Nault

    Résumé Résumé Plan Plan
  • ·Early repolarization pattern is more frequent but not associated with greater risk of arrhythmic episodes in patients with long-QT syndrome

    Page :85

    R. Chauvel, M. Audoubert, F. Sebai, F. Sacher, V. Probst, J.B. Gourraud, A. Rollin, P. Maury

    
  • ·Genome wide analysis of sotalol-induced IKr inhibition during ventricular repolarization, “GENEREPOL study”: lack of common variants with large effect sizes

    Page :85-86

    J. Salem, M. Germain, J. Hulot, P. Voiriot, B. Lebourgeois, J. Waldura, D. Tregouet, B. Charbit, C. Funck-Brentano

    Résumé Résumé Plan Plan
  • ·Research of QT and QTc intervals dispersion in sporting teenagers

    Page :86

    L. Dimitriu, A. Dimitriu

    
  • ·A new automated ultra-high resolution mapping system allows detection of very low voltage critical signals in scarred human atria

    Page :86

    D. Latcu, S. Bun, F. Viera, T. Delassi, A. Alamourh, N. Saoudi

    
  • ·Finding the critical isthmus of reentrant scar-related atrial arrhythmias based on electrophysiological properties: new data from the automated ultra-high resolution mapping

    Page :86

    D. Latcu, S. Bun, F. Viera, T. Delassi, A. Alamourh, N. Saoudi

    
  • ·Effective mechanical resynchronization after device implantation rather than baseline dyssynchrony to predict positive outcome after cardiac resynchronisation therapy

    Page :87

    G. Viart, B. Godin-Gardea, F. Bauer, D. Stepowski, B. Glinel, H. Eltchaninoff, E. Durand, N. Auquier, A. Mirolo, A. Savouré, F. Anselme

    
  • ·Left ventricular ejection fraction assessment to select patients for primary prevention with implantable cardioverter defibrillator using cardiac magnetic resonance imaging or echocardiography

    Page :87

    L. Champ-Rigot, P. Gay, L. Benouda, D. Legallois, J. Alexandre, R. Morello, E. Saloux, P. Milliez

    
  • ·Heart transplant patients with pacemaker: predictive factors for pacemaker requirement for type of bradyarrhythmias and prognosis factors for survival

    Page :87

    J. Fedida, X. Waintraub, G. Duthoit, J.L. Golmard, S. Varnous, N. Badenco, C. Himbert, R. Frank, A. Pavie, F. Hidden-Lucet, P. Leprince, E. Gandjbakhch

    
  • ·Global longitudinal strain in myotonic dystrophy type 1 patients during right ventricular pacing comparative study

    Page :87-88

    C. Goujeau, R. Garcia, C. Fontaine, B. Degand, F. Le Gal, L.P. Christiaens

    Résumé Résumé Plan Plan
  • ·Reproducibility of intracardiac electrocardiogram measurements in the diagnosis of patients with syncope

    Page :88

    P.M. Lallemand, M.S. Younsi, C. Coquart, S. Dinanian, C. Sebag, V. Algalarrondo

    
  • ·Clinical predictors of challenging atrioventricular node ablation for rate control in patients with atrial fibrillation

    Page :89

    B. Polin, N. Behar, V. Auffret, D. Pavin, P. Mabo, C. Leclercq, J.C. Daubert, R. Martins

    
  • ·High risk of heart failure in desmoglein-2 mutation carriers in arrhythmogenic right ventricular dysplasia/cardiomyopathy

    Page :89

    A. Hermida, V. Fressart, F. Hidden-Lucet, E. Donal, V. Probst, J.C. Deharo, P. Chevalier, D. Klug, N. Mansencal, E. Delacretaz, P. Cosnay, P. Scanu, F. Extramiana, D. Keller, P. Charron, E. Gandjbakhch

    
  • ·Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation in acute coronary syndrome

    Page :89

    C. Arantes, G. Abreu, C. Quina-Rodrigues, S. Fonseca, S. Magalhães, A. Salgado, A. Gaspar, S. Rocha, J. Marques

    
  • ·Sleep apnea syndrome in a multicentric study on patients with device remote monitoring system

    Page :90

    S. Venier, P. Bordachar, R. Eschalier, P. Mondoly, P. Jacon, P. Defaye

    

• Topic 06 - Arterial hypertension / Vascular disease

  • ·Does resistant hypertension still exist? Role of spironolactone

    Page :91

    E. Ouzan, C. Lotan

    
  • ·Primary aldosteronism and left ventricle in 2D echocardiography: new insights

    Page :91

    R. Boulestreau, A. Cremer, M. Laine, P. Gaillard, G. Papaioannou, P. Gosse

    
  • ·Renin-angiotensin system genes polymorphisms and essential hypertension in Burkina Faso, West Africa

    Page :91-92

    K. Kologo, D. Tchelougou, D.S. Karou, N.V. Yaméogo, C. Bisseye, F. Djigma, D. Ouermi, T.R. Compaore, M. Assih, V. Pietra, G.R.C. Millogo, G. Kinda, A.K. Samadoulougou, P. Zabsonre, J. Simpore

    Résumé Résumé Plan Plan
  • ·Screening for sleep apnea syndrome in post-menopausal women at cardiovascular risk

    Page :92

    A. Madika, S. Sediri, C. Monaca, F. Boudghene, P. Delsart, G. Ledieu, C. Mounier-Vehier

    
  • ·Behcet’s disease with anti phospholipid antibodies: what about thromboembolic risk?

    Page :92-93

    O. Berriche, S. Hammami, M.H. Sfar, M. Hammami

    Résumé Résumé Plan Plan
  • ·Prognostic value of ankle-brachial index according to methods of its calculation in patients undergoing coronary bypass surgery

    Page :93

    L. Lebivic, J. Magne, I. Desormais, A. Piccardo, P. Lacroix, D. Mohty, V. Aboyans

    
  • ·Aortic Atherosclerosis is a key modulator of the prognostic value of postural blood pressure changes

    Page :93

    P. Courand, B. Harbaoui, H. Fay, F. Khettab, H. Milon, P. Lantelme

    
  • ·Aortic stiffness aging is influenced by past profound immunodeficiency in HIV-infected individuals

    Page :93-94

    L. Maia-Leite, E. Catez, A. Boyd, S. Lang, N. Haddour, A. Curjol, M. Nuernberg, C. Duvivier, M. Desvarieux, M. Kirstetter, P.M. Girard, F. Boccara, A. Cohen

    Résumé Résumé Plan Plan
  • ·Plasma NT-proBNP mirrors the deleterious cardiovascular and renal continuum in hypertension

    Page :94

    P. Courand, B. Harbaoui, C. Becle, C. Moule-Bertin, P. Lantelme

    
  • ·Angiopoietin-like 2 is associated with increased risk of cardiovascular events and death in diabetic patients

    Page :94

    B. Gellen, N. Thorin-Trescases, P. Sosner, E. Gand, P.J. Saulnier, S. Ragot, M. Fraty, S. Laugier, G. Ducrocq, D. Montaigne, P. Llaty, V. Rigalleau, P. Zaoui, J.M. Halimi, R. Roussel, E. Thorin, S. Hadjadj

    
  • ·Relation between alkaline phosphatase and coronary artery calcification in subjects free of cardiovascular disease

    Page :94-95

    L. Panh, H. Rousseau, A. Petermann, D. Taraszkiewicz, V. Bongard, O. Lairez, J.B. Ruidavets, J. Ferrières

    Résumé Résumé Plan Plan

• Topic 07 - Basic research

  • ·GWAS-driven pathway analyses and functional studies reveals GLIS1 to predispose to mitral valve prolapse

    Page :96

    M. Yu, C. Dina, N. Tucker, F. Delling, S. Slaugenhaupt, R.A. Levine, A.A. Hagège, J. Schott, X. Jeunemaitre, D. Milan, R. Norris, N. Bouatia-Naji

    
  • ·L-type Cav1.3 and T-type Cav3.1 calcium channels in cardiac pacemaker activity

    Page :96

    M. Baudot, M.E. Mangoni, P. Mesirca, I. Bidaud, A. Chung You Chong, L. Talssi

    
  • ·Plasma from patients with calcified aortic disease triggers an osteoblast-like phenotype switch in human aortic valve interstitial cells

    Page :96-97

    L. Cattan Levy, M.P. Jacob-Lenet, M.P. Dehoux, C. Deschildre, I. Codogno, M. Morvan, A.T. Gaston, G. Even, J. Michel, D. Messika-Zeitoun, A. Nicoletti, G. Caligiuri, J. Laschet

    Résumé Résumé Plan Plan
  • ·Role of cAMP-phosphodiesterases in cardiac recovery after ?–adrenergic stimulation: an in vivo preliminary study

    Page :97

    R. Huguet, G. Vandecasteele, R. Fischmeister, V. Algalarrondo

    
  • ·An in vitro model to study impact of glucose fluctuations on cellular and mitochondrial cardiac functions

    Page :97

    P. Mordel, M. Nowoczyn, M. Joubert, L. Coulbault, S. Allouche

    
  • ·Involvement of oxidative and inflammatory components in the development of atherosclerosis and the severity of coronary artery disease

    Page :97

    S. Hadj Ahmed, N. Koubaa, S. Hammami, W. Kharroubi, A. Zarrouk, A. Mnari, H. Gamra, F. Betbout, I. Hininger, M. Hammami

    
  • ·Benefits of human cardiac progenitor cell-seeded collagen patches applied on failing right ventricle: progenitor cells differentiation/migration may impact the RV function

    Page :98

    V. Lambert, J. Boissadier, C. Rucker-Martin, A. Hodzic, M. Ly, E. Le Bret, N. Borenstein, M. Puceat

    
  • ·Paraoxonase 3 (PON3) polymorphisms, haplotypes and risk of myocardial infarction in the Tunisian population

    Page :98

    M. Sbai, A. Kallel, S. Ben Wafi, M. Ben Halima, M. Soussi, A. Baara, I. Mahjoubi, Z. Jemaa, M.S. Mourali, R. Jemaa, N. Kaabachi

    
  • ·Aortic valve disease acquired after left ventricular assist device implantation: an outstanding in vivo model of valvular heart disease pathophysiology and remodeling

    Page :98

    A. Theron, E. Faure, A. Pistol, J.P. Desvignes, G. Collod-Beroud, J.F. Avierinos, F. Collart, S. Zaffran

    
  • ·Extracellular matrix remodeling in hypertrophic cardiomyopathy

    Page :98-99

    N. Fourty, A. Abbes, A. Zaroui, S. Aloui, W. Zidi, M. Ben Halima, M. Feki, R. Mechmeche, M.S. Mourali, M. Allal Elasmi, N. Kaabachi

    Résumé Résumé Plan Plan
  • ·Methionine synthase (Mtr) promote the development of cardiac hypertrophy and heart failure

    Page :99

    F. Elkhafifi, Z. Li, C. Arnold, P. Lacolley, D. Umoret, A. Mohamadi, L. Monassier, G. Bouabout, D. Lambert, F. Maskali, J.L. Guéant, R. Guéant-Rodriguez

    

• Topic 08 - Cardiovascular rehabilitation and sport

  • ·Time trends in hospitalizations for cardiac rehabilitation post-acute myocardial infarction in France, 2010-2014

    Page :100

    A. Gabet, C. De Peretti, V. Olié

    
  • ·Barriers to prescription of cardiac rehabilitation after acute myocardial infarction in France

    Page :100

    C. Minvielle, J. Corré, H. Douard

    
  • ·Cardiac rehabilitation for heart assist device patients: a preliminary register from 7 French centers

    Page :100

    S. Kubas, A. Tisseau, S. Durand, P. Bernard, M.A. Mouvier, M.C. Boiteux, M.C. Iliou

    
  • ·Improvement of arterial stiffness in a cardiac rehabilitation programme: a French monocentric study

    Page :100-101

    B. Pavy, M. Hallab, J. Darchis, E. Merle, M. Caillon

    Résumé Résumé Plan Plan
  • ·High efficiency of the screening for diabetes and prediabetes in cardiac rehabilitation (CR) after an acute coronary syndrome (ACS). Data from the prospective READIAB study

    Page :101

    B. Vergès-Patois, A. Nguyen, M.C. Blonde, B. Vergès

    
  • ·A maintenance exercise program improve physical capacity and level in patients with heart failure, at 12 months after center-based cardiac rehabilitation

    Page :101

    P. Blanc, G. Caderby, E. Galent, N. Berjeb, C. Morice, S. Maunier

    
  • ·Creation of the first cardiac rehabilitation unit in Moroccan hospital

    Page :101-102

    N. Mouine, N. Loudiyi, I. Asfalou, M. Raissouni, M. Sabry, Z. Lakhal, N. Berrada, A. Benyass, E. Zbir

    Résumé Résumé Plan Plan
  • ·Unexpected effects of exercise-based cardiac rehabilitation on changes in metabolic, mechanical and neuromuscular responses observed during cardiopulmonary exercise testing

    Page :102

    P. Leprêtre, A. Barnabé, L. Gaillard, S. Delanaud, N. Jaunet, M. Ghannem, T. Porcher

    
  • ·Left atrial function assessment in athletes

    Page :102

    C. Hedon, S. Cade, D. Matelot, F. Cransac, E. Donal, F. Schnell, F. Carre

    
  • ·Arrhythmogenic right ventricular cardiomyopathy or athlete’s heart adaptations?

    Page :102-103

    A. Zaroui, Z. Rezine, R. Mechmeche

    Résumé Résumé Plan Plan
  • ·Benefit of cardiac rehabilitation in pre diabetic patients with coronary artery disease

    Page :103

    N. Mouine, G. Amah, C. Guiti, S. Gagey, M. Duval, K. Abdennbi

    
  • ·Is there a disassociation of ventilatory and electromyographic thresholds in patients with heart disease during a graded cycling exercise?

    Page :103

    P. Leprêtre, L. Gaillard, A. Barnabé, S. Delanaud, T. Porcher, M. Ghannem, N. Jaunet

    
  • ·Ambulatory blood pressure reduction following 2 weeks of high-intensity interval training performed on ergo-cycle in water or dry land condition

    Page :103-104

    P. Sosner, M. Gayda, O. Dupuy, M. Garzon, C. Lemasson, V. Gremeaux, J. Lalongé, M. Gonzales, D. Hayami, M. Juneau, A. Nigam, L. Bosquet

    Résumé Résumé Plan Plan
  • ·Do 4 days of intense french military marine commandos selection camp induce cardiac fatigue?

    Page :104

    D. Matelot, F. Schnell, G. Kervio, E. Galli, N. Ville, F. Carré

    
  • ·Assessment of premature ventricular beats in athletes

    Page :104-105

    A. Ben Halima, D. Kobaa, H. Ben Salah, M. Belkhiria, S. Ayachi, H. Addala, M. Zaaibi

    Résumé Résumé Plan Plan
  • ·Is systematic echocardiography prior to integration of sports students necessary?

    Page :105

    A. Ben Halima, D. Kobaa, S. Abdelmalek, H. Addala, M. Belkhiria, S. Ayachi, M. Zaabi

    
  • ·The prevalence of athletes’ ECG abnormalities based on refined criteria is not impacted by the dynamic/static components of sports

    Page :105

    N. Maillot, S. Aho-Glele, A. Gudjoncik, C. Guenancia, F. Chagué, Y. Cottin

    

• Topic 09 - Prevention / Epidemiology / Nutrition

  • ·Cardiovascular effects of air pollution: a review

    Page :106

    T. Bourdrel, T. Reeb, O. Morel, J.F. Argacha

    
  • ·Cardiovascular risk factors among 94 473 acute coronary syndrome patients in Europe

    Page :106

    S. Huo Yung Kai, I. Roman Degano, A. Malmivaara, I. Kirchberger, D. Farmakis, M. Torre, A. Azevedo, D. Fusco, M. Davoli, J. Marrugat, J. Ferrières

    
  • ·Lack of comprehensive cardiac investigations in cases of apparently idiopathic ventricular fibrillation in the community

    Page :106-107

    V. Waldmann, W. Bougouin, M.C. Bories, D. Jost, B. Ludes, V. Algalarrondo, E. Gandjbakck, N. Lellouche, F. Beganton, L. Lamhaut, T. Lavergne, F. Extramiana, X. Jouven, E. Marijon

    Résumé Résumé Plan Plan
  • ·Behaviours of amateur rugby players are not safe for their hearts

    Page :107

    J. Petit, F. Chagué, J.C. Peyrin, J.P. Hager, P. Aviat, Y. Laurent, A. Gudjoncik, M. Zeller, Y. Cottin, V. Gremeaux

    
  • ·Poor cardiovascular health as a risk marker for excessive daytime sleepiness: the Paris prospective study 3

    Page :108

    Q. Lisan, P. Boutouyrie, B. Gaye, M. Tafflet, F. Thomas, C. Guibout, M.C. Périer, P. Bonfils, B. Pannier, X. Jouven, J.P. Empana

    
  • ·Impact of neighborhood socio-economic status on bystander cardiopulmonary resuscitation in Paris

    Page :108

    B. Dahan, P. Jabre, N. Karam, R. Misslin, M. Tafflet, W. Bougouin, D. Jost, F. Beganton, E. Marijon, X. Jouven

    
  • ·Improvement in achievement of lipid targets in France: comparison of data from the DYSIS I and DYSIS II studies

    Page :108-109

    J. Ferrières, M. Velkovski Rouyer, D. Lautsch, V. Ashton, B.M. Ambegaonkar, P. Brudi, A.K. Gitt

    Résumé Résumé Plan Plan
  • ·Prevalence of smoking cessation in coronary patients: preliminary results of a Tunisian experience

    Page :109

    H. Abroug, A. Elhraiech, A. Sriha Belguith, O.N.S. Mehrez, K. Ben Salem, M. Soltani

    
  • ·Magnitude, pattern and determinants of left ventricular geometry changes in obese subjects

    Page :109

    M. Iancu, G. Badea, M. Dumitrescu, C. Copaescu, I. Craciunescu, L. Alecu, S. Vasile, G. Ursu, M. Serban, C. Ginghina

    
  • ·Are the LDL-cholesterol targets from the ESC/EASD guidelines achievable in diabetic patients?

    Page :109-110

    J. Dillinger, T. Vidal-Trecan, B. Merat, G. Sideris, J.P. Kevorkian, J.F. Gautier, J.P. Riveline, P. Henry

    Résumé Résumé Plan Plan
  • ·CARDIOSAS: a questionnaire by the “Cercle Coeur et Sommeil” to screen for Sleep Apnea in cardiovascular patients of private practice

    Page :110

    P. Escourrou, D. Bennegadi, F. David, P. Delmas, A.L. El Hallak, P. Ghassemi, A. Gounaropoulos, N. Houdard, M.P. Houppe-Nousse, J.P. Labarre, B. Mafart, M. Pretorian, P. Samama, Z. Balekji, C. Colas Des Francs, N. Puisais, J.M. Davy, E.T. Cercle Coeur Et Sommeil

    
  • ·Inappropriate intensity statin therapy causing worse lipid profiles in HIV-infected individuals after acute coronary syndrome

    Page :110

    F. Boccara, J. Miantezila-Basilua, M. Mary-Krause, S. Lang, E. Teiger, C. Funck-Brentano, P.M. Girard, D. Costagliola, A. Cohen, M. Guiguet

    
  • ·Score of adherence to European cardiovascular prevention guidelines is an independent determinant of cardiovascular and all-cause mortality in the general population

    Page :110-111

    E. Bérard, V. Bongard, D. Arveiler, J. Dallongeville, A. Wagner, P. Amouyel, B. Haas, D. Cottel, J.B. Ruidavets, J. Ferrières

    Résumé Résumé Plan Plan
  • ·Heterozygous familial hypercholesterolemia: from a clinical suspicion to a genetic confirmation

    Page :111

    F. Séguro, V. Bongard, D. Taraszkiewicz, F. Bouisset, J.B. Ruidavets, J. Ferrières

    
  • ·“Heart, arteries and women”, a healthcare pathway for women at cardiovascular risk: evaluation at three years

    Page :111

    A. Madika, C. Lecerf, B. Letombe, F. Boudghene, P. Delsart, G. Ledieu, C. Mounier-Vehier

    
  • ·Fatty Liver Index is an independent determinant of long-term cardiovascular and all-cause mortality

    Page :111-112

    E. Bérard, V. Bongard, D. Arveiler, J. Dallongeville, A. Wagner, P. Amouyel, B. Haas, D. Cottel, J.B. Ruidavets, J. Ferrières

    Résumé Résumé Plan Plan
  • ·Trends of in-hospital and out-of-hospital coronary heart disease mortality rates in French registers in the period 2000-2013

    Page :112

    A. Wagner, B. Haas, M. Montaye, J.B. Ruidavets, J. Dallongeville, J. Ferrières, D. Arveiler

    

• Topic 10 - Pediatrics and congenital cardiopathies

  • ·Long-term functional and myocardial assessment in patients with critical aortic valve stenosis

    Page :113

    B. Bonello, M. Carr, X. Iriart, G. Derrick, G. Christov, M. Kostolny, J. Marek

    
  • ·The Amplatzer Duct Occluder II additional sizes device for transcatheter PDA closure in preterms infants: monocentric experience

    Page :113

    A. Chalard, M. Lang, B. Cosserant, F. Rusé, J.R. Lusson, B. Boeuf, C. Dauphin

    
  • ·Infective endocarditis in children: morbi-mortality and impact of congenital heart disease

    Page :113

    P. Aldebert, M. Orabonna, G. Habib, J.P. Casalta, J.P. Pinto, C. Ovaert, L. Mace

    
  • ·Describing and improving care pathways to improve health systems in adults with congenital heart disease (ACHD): the PROSPECT study

    Page :114

    S. Cohen, C. Gueri, Q. Garnier, A. Burgun, L. Iserin

    
  • ·Outcome of symptomatic partial atrioventricular septal defect requiring repair during infancy: a multicentric study

    Page :114

    S. Krupickova, G. Morgan, M.H. Cheang, O. Ghez, A. Battista, A. Spanaki, R. Franklin, A. Desai, A. Fraisse

    
  • ·Impact of conversion from classic Fontan to total cavopulmonary connection on adults with single-ventricle short and long-term outcomes

    Page :114

    B. Ankou, J. Ninet, A. Bozio, C. Ducreux, M. Bakloul, C. Bertail-Galoin, S. Di Filippo

    
  • ·Pulmonary artery size evaluated by Nakata index predicts mortality in absent pulmonary valve syndrome

    Page :114-115

    D. Laux, Y. Karaca, M. Gouton, M. Bensemlali, J. Hoerer, D. Bonnet

    Résumé Résumé Plan Plan
  • ·Risk factor for heart failure admissions in adults with congenital heart disease in monocentric tertiary center

    Page :115

    N. Ben Moussa, F. Pontnau, Y. Boudjemline, A. Legendre, L. Iserin, D. Bonet, M. Ladouceur

    
  • ·Cardiopulmonary exercise test among children with congenital heart diseases: a multicenter study

    Page :115

    P. Amedro, A. Gavotto, S. Guillaumont, M. Vincenti, G. De La Villeon, C. Soulatges, C. Bredy, S. Matecki

    
  • ·Prevalence of early repolarization in children

    Page :115-116

    D. Sumanaru, C. Authenac, S. Hascoët, K. Hadeed, C. Karsenty, P. Acar, P. Maury, Y. Dulac

    Résumé Résumé Plan Plan
  • ·Acute myocarditis in very young children: single center experience

    Page :116

    C. Walton, M. Veyrier, C. Ducreux, R. Henaine, S. Di Filippo

    
  • ·Clinical accuracy of annual cardiac computed tomography angiography in pediatric heart transplant recipients

    Page :116

    O. Guillard, A. Rhonean, N. Tô, J.F. Paul, L. Houyel

    
  • ·Transcatheter closure of large atrial septal defects (ASDs) in symptomatic children with device/weight ratio 1.5. European multicentric study

    Page :116

    A. Houeijeh, F. Godart, S. Hascoet, H. Bouvaist, J. Petit, A. Fraisse

    
  • ·Effect of percutaneous stent implantation on arterial hypertension and aortic flow dynamics in patients with aortic coarctation: identification of responders and non responders

    Page :117

    J. Laik, X. Iriart, Z. Jalal, P. Moceri, F. Squara, G. Farrugia, J.B. Thambo

    

• Topic 11 - Surgery

  • ·The French National Registry (N.O.E.) of elective frozen elephant trunk surgery using the Evita Open Plus: early and mid-term outcomes

    Page :118

    J.P. Verhoye, A. Anselmi, R. Belhaj, F. Farhat, J.P. Couetil, T. Caus, S. Chocron, E. Choukroun, E. Bezon, D. Grisoli, R. Demaria, P. Maureira, C. Jayle, P. Leprince, A. Mirza, N. Bischoff, J.G. Kretz, O. Fouquet

    
  • ·Cardiac surgery in deprived settings: 10 years’ experience in two lowincome countries

    Page :118-119

    M. Mirabel, M. Lachaud, L. Offredo, C. Lachaud, B. Zuschmidt, B. Ferreira, D. Sidi, S. Chauvaud, P. Sok, A. Deloche, E. Marijon, X. Jouven

    Résumé Résumé Plan Plan
  • ·Mid- and long-term prognosis of on- vs. off-pump coronary artery bypass graft in patients with multisite artery disease

    Page :119

    L. Lebivic, J. Magne, A. Piccardo, F. Rollé, P. Lacroix, D. Mohty, V. Aboyans

    
  • ·Heart transplantation in infants and children on mechanical ventricular support

    Page :119

    M. Veyrier, C. Ducreux, R. Henaine, J. Ninet, C. Bertail-Galoin, M. Bakloul, S. Di Filippo

    

• Topic 13 - Emergency care and intensive cardiac care

  • ·Can cardiac troponin I measurement help to predict recent coronary occlusion in out-of-hospital cardiac arrest survivors?

    Page :120

    A. Asadi, N. Barber-Chamoux, P. Motreff, J.R. Lusson

    
  • ·Prediction of 30-day outcome for out of hospital cardiac arrest survivers (OHCAS)

    Page :120

    J. Higny, J. Jamart, L. De Cannière, C. Boulouffe, X. Muschart, V. Gérard, D. Vanpee, A. Dive, P. Evrard, F. Feye, F. Foret, D. Darii, C. Hanet, L. Gabriel, V. Dangoisse, A. Guédès, E. Schröder

    
  • ·Out of hospital cardiac arrest due to coronary spasm: should an implanted defibrillator systematically be considered?

    Page :120

    G. Cherif, J.L. Georges, G. Gibault-Genty, E. Blicq, B. Ajlani, R. Convers-Domart, C. Charbonnel, N. Baron, G. Galuscan, A. Vienet Legue, F. Boutot, S. Legriel, B. Livarek

    
  • ·Predictive value of clinical and electrocardiographic features in survivors of out-of-hospital cardiac arrest

    Page :121

    A. Asadi, N. Barber-Chamoux, P. Motreff, J.R. Lusson

    
  • ·Factors predictive of survival after out-of-hospital cardiac arrest

    Page :121

    A. Asadi, N. Barber-Chamoux, P. Motreff, J.R. Lusson

    
  • ·Early identification of out-of-hospital cardiac arrest patients with no chance of survival for orientation towards organ donation

    Page :121

    P. Jabre, W. Bougouin, F. Dumas, P. Carli, C. Antoine, L. Jacob, B. Dahan, F. Beganton, J.P. Empana, E. Marijon, N. Karam, D. Jost, A. Loupy, C. Lefaucheur, A. Cariou, F. Adnet, T. Rea, X. Jouven

    
  • ·Effect of blood transfusion in elderly patients with acute myocardial infarction on one-year mortality

    Page :121-122

    S. Perrin, A. Putot, J.C. Beer, M. Maza, Y. Cottin, M. Zeller, P. Manckoundia

    Résumé Résumé Plan Plan
  • ·Predominance of hypertension – related morbidity and mortality at the cardiovascular intensive care unit in a Sub – Saharan African tertiary hospital

    Page :122

    M. Hongieh Abanda, A. Simo, A. Dzudie, L.N. Aminde, Y. Mapoure, F. Kamdem, A. Kana, H.N. Luma

    
  • ·Characteristics and long-term prognosis of patients with Myocardial Infarction, Non-Obtructive Coronary Arteries (MINOCA) and an inconclusive Cardiac Magnetic Resonance (CMR)

    Page :122

    E. Collette, G. Leurent, V. Auffret, P. Lentz

    
  • ·Cardiovascular emergencies in the department of cardiology and internal medicine at the teaching hospital of Brazzaville (Congo)

    Page :122-123

    B. Ellenga Mbolla, E. Kimbally Kaky, C. Kouala Landa, F.S. Mongo Née Ngamami, M.S. Ikama, S.G. Kimbally Née Kaky

    Résumé Résumé Plan Plan
  • ·Cardiogenic shock: place of comorbidities and prior use of beta-blockers

    Page :123

    C. Delmas, E. Orloff, T. Moine, B. Citoni, C. Biendel, O. Lairez, D. Carrie, M. Galinier, F. Bouisset, M. Elbaz

    
  • ·Long-term clinical outcomes in patients with cardiogenic shock according to lelf ventricular function: the FAST-MI 2010 registry

    Page :123

    E. Puymirat, E. Riant, N. Aissaoui, L. Bonello, C. Delmas, F. Schiele, P. Henry, E. Bonnefoy, T. Simon, N. Danchin

    
  • ·Activated clotting time versus antiXa activity for anticoagulation monitoring during ECMO support: a concordance study

    Page :123-124

    A. Jacquemin, C. Delmas, J.M. Conil, N. Hernandez, P. Guerrero, V. Minville, B. Marcheix, B. Georges

    Résumé Résumé Plan Plan
  • ·Evolution of early mortality in diabetic patients after myocardial infarction according to the change in reperfusion strategy

    Page :124

    T. Spingarn, T. Bochaton, E. Flocard, E. Bonnefoy-Cudraz, C. Elkhoury